Bourgeon Capital Management LLC Omeros Corp Transaction History

Bourgeon Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 20, 2023	SELL	$1.75 - $3.96 $4,812 - $10,890	-2,750 Reduced 78.57%	750 $0
Q3 2022 Oct 27, 2022	BUY	$3.09 - $7.46 $10,815 - $26,110	3,500 New	3,500 $11,000
Q4 2020 Jan 29, 2021	SELL	$10.14 - $15.19 $243,360 - $364,560	-24,000 Closed	0 $0
Q3 2020 Oct 28, 2020	BUY	$9.57 - $21.32 $229,680 - $511,680	24,000 New	24,000 $243,000
Q1 2020 May 07, 2020	SELL	$9.03 - $19.72 $43,795 - $95,642	-4,850 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$13.01 - $17.15 $30,573 - $40,302	2,350 Added 94.0%	4,850 $68,000
Q3 2019 Nov 04, 2019	BUY	$14.55 - $20.56 $36,375 - $51,400	2,500 New	2,500 $41,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $620M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Bourgeon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Bourgeon Capital Management LLC with notifications on news.